Literature DB >> 22854067

Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.

Kuo-Wei Chang1, Shou-Yen Kao, Yi-Hsuan Wu, Meng-Miao Tsai, Hsi-Feng Tu, Chung-Ji Liu, Mann-Tin Lui, Shu-Chun Lin.   

Abstract

OBJECTIVES: MicroRNAs (miRNAs) are endogenous small non-coding RNAs that negatively regular target gene expression by RNA interference. The processing of the pre-miRNA hairpin generates a miRNA duplex, which consists of a miRNA (guide strand) and a miRNA(*) (passenger strand). miR-31 is an oncogenic miRNA and is up-regulated in oral squamous cell carcinoma (OSCC). miR-31(*) shows a high level of conservation across species and, based on this, this study hypothesized that miR-31(*) is a functional miRNA.
MATERIALS AND METHODS: The expression of miR-31 and miR-31* in OSCC tissues and oral cells were analyzed. Functional studies were performed on OSCC cells.
RESULTS: miR-31(*) is up-regulated in OSCC tissues, but its expression is less abundant than miR-31. miR-31(*) decreases the proliferation and migration of both SAS and Fadu cells. Furthermore, miR-31(*) targets the 3'UTR of RhoA and is able to down-regulate RhoA expression. Knockdown of RhoA expression is known to decrease the proliferation and migration of OSCC cells. However, up-regulation of both miR-31 and miR-31(*) by delivery of pre-mir-31 does still enhance OSCC oncogenicity.
CONCLUSION: miR-31(*) is a functional miRNA involving in regulating RhoA, and the activity of miR-31(*)'s activity seems to counteract the functions of miR-31 during OSCC tumorigenesis.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22854067     DOI: 10.1016/j.oraloncology.2012.07.003

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  30 in total

1.  Effects of isoprenylcysteine carboxyl methyltransferase silencing on the proliferation and apoptosis of tongue squamous cell carcinoma.

Authors:  Shao-Ru Wang; Wei Sun; Nan Zhou; Kai Zhao; Wen-Jian Li; Zeng-Peng Chi; Ying Wang; Qi-Min Wang; Lei Tong; Zong-Xuan He; Hong-Yu Han; Zheng-Gang Chen
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-02-01

2.  The role of RhoA in vulvar squamous cell carcinoma: a carcinogenesis, progression, and target therapy marker.

Authors:  Jing Wang; Qiong Wu; Li-Hua Zhang; Yun-Xia Zhao; Xin Wu
Journal:  Tumour Biol       Date:  2015-09-26

Review 3.  MicroRNA-regulated viral vectors for gene therapy.

Authors:  Anja Geisler; Henry Fechner
Journal:  World J Exp Med       Date:  2016-05-20

4.  microRNA regulation in cancer: One arm or two arms?

Authors:  Ramkrishna Mitra; Jingchun Sun; Zhongming Zhao
Journal:  Int J Cancer       Date:  2015-04-20       Impact factor: 7.396

5.  Plasma miR-187* is a potential biomarker for oral carcinoma.

Authors:  Chung-Ji Liu; Jiun-Sheng Lin; Hui-Wen Cheng; Ya-Hui Hsu; Chieh-Yuan Cheng; Shu-Chun Lin
Journal:  Clin Oral Investig       Date:  2016-06-20       Impact factor: 3.573

Review 6.  Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL).

Authors:  Krystyna Mazan-Mamczarz; Ronald B Gartenhaus
Journal:  Leuk Res       Date:  2013-09-07       Impact factor: 3.156

7.  MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis.

Authors:  Kai Fang; Ivy Ka Man Law; David Padua; Aristea Sideri; Vanessa Huang; Christopher G Kevil; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2017-12-16       Impact factor: 4.307

8.  MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.

Authors:  Alireza Korourian; Raheleh Roudi; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Exp Biol Med (Maywood)       Date:  2017-08-24

9.  Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.

Authors:  Elisa Araldi; Aranzazu Chamorro-Jorganes; Coe van Solingen; C Fernández-Hernando; Y Suárez
Journal:  Curr Vasc Pharmacol       Date:  2013-05-13       Impact factor: 2.719

10.  Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice.

Authors:  Kefei Yuan; Ke Xie; John Fox; Huawei Zeng; Hongwei Gao; Canhua Huang; Min Wu
Journal:  Gastroenterology       Date:  2013-06-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.